Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
Not yet recruiting · NCT07611149 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 1 | 2026-05-28 | NCT07611149 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CellServe LLC | 1 |
| Kure Cells, INC | 2 |
| Roya Clinical | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||